Intrinsiqq
OKYO Pharma Ltd. logo

OKYO Pharma Ltd. Insider Trading

OKYO

Compare
Last 12 months

Insiders bought 136K on the open market and sold nothing.

Net open-market
+136K
7 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
6 / 0
executives and directors
Last open-market buy
Jul 2026
Jul 27, 2026

Get an email when OKYO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jul 27
    Rajkumar V. Patil
    Chief Scientific Officer · bought 3,363 at $1.49
    5K
    20% of stake
  • Jul 22
    Robert John Dempsey
    Chief Executive Officer · bought 15,000 at $1.54
    23K
    New position
  • Jul 21
    John P Brancaccio
    Director · bought 5,000 at $1.48
    7K
    17% of stake
  • Jul 21
    Gary S Jacob
    Chief Development Officer · bought 3,500 at $1.40
    5K
    3.2% of stake
  • Jul 21
    Flavio Mantelli
    Chief Medical Officer · bought 20,000 at $1.40
    28K
    New position
  • Jul 21
    Gabriele M Cerrone
    Director · bought 22,500 at $1.45
    33K
    0.2% of stake
  • Jul 20
    Gabriele M Cerrone
    Director · bought 25,000 at $1.40
    35K
    0.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OKYO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biotechnology · Pick stocks to compare with OKYO

CompareIntrinsic value
NEWBRY.XSTONewbury Pharmaceuticals AB
€0.11+0.91%40
HPHA.XETRHeidelberg Pharma AG
€2.01-2.90%10
MEDCL.XPARMedincell SA
€26.70-2.05%40
ZTEKZentek Ltd.
€0.33-0.60%40
XTXXFAdastra Holdings Ltd.
€0.08+0.00%40
XRTXXORTX Therapeutics Inc.
$0.84-5.73%10
VALNValneva SE Sponsored ADR
$5.16-3.82%0
TRIBTrinity Biotech plc Sponsored ADR
$6.24+13.66%10

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing OKYO

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.